Treatment trials in aging and mild cognitive impairment

Current Topics in Behavioral Neurosciences

Volumn 10, Issue , 2011, Pages 347-356

  Corey Bloom, Jody ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Clinical trials; Mild cognitive impairment; Treatment

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DONEPEZIL; GALANTAMINE; NOOTROPIC AGENT; PLACEBO; RIVASTIGMINE; ROFECOXIB;

AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL RESEARCH; COGNITION; CONTROLLED CLINICAL TRIAL (TOPIC); DEMENTIA; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; GINKGO BILOBA; MILD COGNITIVE IMPAIRMENT; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; ANIMAL; CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY;

AGING; ANIMALS; CLINICAL TRIALS AS TOPIC; HUMANS; MILD COGNITIVE IMPAIRMENT; RESEARCH DESIGN;

EID: 84901060260     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2011_153     Document Type: Article

References (13)

1. Aisen PS (2002) The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 1(5): 279-284
2. Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ, Alzheimer's Disease Cooperative Study (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289(21): 2819-2826
3. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, Ginkgo Evaluation of Memory (GEM) Study Investigators (2008) Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 300(19): 2253-2262
4. Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK (2009) Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Neurology 72(18): 1555-1561
5. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, Tekin S, Burns A, Cummings J, del Ser T, Inzitari D, Orgogozo JM, Sauer H, Scheltens P, Scarpini E, Herrmann N, Farlow M, Potkin S, Charles HC, Fox NC, Lane R (2007) Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol 6(6): 501-512 Erratum in: Lancet Neurol. 2007 Oct; 6(10): 849
6. Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F (2011) Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 1: CD006220
7. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, Alzheimer's Disease Cooperative Study Group (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352(23): 2379-2388
8. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, Richardson S, Donepezil 401 Study Group (2004) Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 63(4): 651-657
9. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon JCW, Pfeifer E, Schneider LS, Thal LJ, for the Members of the Alzheimer's Disease Cooperative Study (1997) A two-year, double-blind, randomized multicenter trial of Selegiline and α-tocopherol in the treatment of Alzheimer's disease. New Eng J Med 336(17): 1245-1247
10. Thal LJ, Ferris SH, Kirby L, Block GA, Lines CR, Yuen E, Assaid C, Nessly ML, Norman BA, Baranak CC, Reines SA, Rofecoxib Protocol 078 study group (2005) A randomized, doubleblind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology 30(6): 1204-1215
11. Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, Soumbourou A, Nikolaidou E, Batsila G, Siambani A, Nakou S, Mouzakidis C, Tsiakiri A, Zafeiropoulos S, Karagiozi K, Messini C, Diamantidou A, Vasiloglou M (2011) Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment. Neurodegener Dis 8(3): 138-145
12. Winblad B, Jelic V (2004) Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors. Alzheimer Dis Assoc Disord 18(Suppl 1): S2-S8
13. Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS, GAL-INT-11/18 Study Group (2008) Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology 70(22): 2024-2035